HAE
Haemonetics Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$59.92
+0.43 ▲ +0.72%
🌙 3월 13일 6:26 PM ET (한국 3/14 07:26)
$59.92
+0.00 +0.00%
| Index | RUT | P/E | 16.46 | EPS (ttm) | 3.64 | Insider Own | 1.43% | Shs Outstand | 0.05B | Perf Week | -6.56% |
| Market Cap | 2.78B | Forward P/E | 11.26 | EPS next Y | 7.57% | Insider Trans | 0.21% | Shs Float | 0.05B | Perf Month | 4.21% |
| Enterprise Value | 3.65B | PEG | 1.24 | EPS next Q | 1.27 | Inst Own | 112.99% | Short Float | 5.91% | Perf Quarter | -31.25% |
| Income | 0.18B | P/S | 2.11 | EPS this Y | 8.25% | Inst Trans | -5.53% | Short Ratio | 3.21 | Perf Half Y | 12.04% |
| Sales | 1.32B | P/B | 3.08 | EPS next 5Y | 9.06% | ROA | 6.99% | Short Interest | 2.71M | Perf YTD | -25.24% |
| Book/sh | 19.46 | P/C | 7.66 | EPS past 3/5Y | 57.59% 17.48% | ROE | 19.3% | 52W High | -31.38% ($87.32) | Perf Year | -9.12% |
| Cash/sh | 7.82 | P/FCF | 9.04 | Sales past 3/5Y | 11.07% 6.6% | ROIC | 9.58% | 52W Low | 26.64% ($47.31) | Perf 3Y | -19.55% |
| Dividend Est. | - | EV/EBITDA | 10.24 | EPS Y/Y TTM | 42.52% | Gross Margin | 55.92% | Volatility(W/M) | 3.95% 3.31% | Perf 5Y | -48.99% |
| Dividend TTM | - | EV/Sales | 2.77 | Sales Y/Y TTM | -4.02% | Oper. Margin | 18.47% | ATR (14) | 2.21 | Perf 10Y | 75.31% |
| Dividend Ex-Date | - | Quick Ratio | 1.15 | EPS Q/Q | 28.61% | Profit Margin | 13.31% | RSI (14) | 35.94 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.75 | Sales Q/Q | -2.75% | SMA20 | -3.3% ($61.96) | Beta | 0.33 | Target Price | $87.5 |
| Payout | - | Debt/Eq | 1.34 | Earnings | 2000000 | SMA50 | -10.95% ($67.29) | Rel Volume | 1.15 | Prev Close | $59.49 |
| Employees | 3023 | LT Debt/Eq | 1.01 | EPS/Sales Surpr. | 4.83% 2.13% | SMA200 | -9.05% ($65.88) | Avg Volume(3M) | 0.84M | Price | $59.92 |
| IPO | 1991/5/10 | Option/Short | Yes/Yes | Trades | 7002 | Volume | 972,700 | Change | 0.72% |
뉴스 로딩 중...